Two Sigma Advisers
AURA icon

Two Sigma Advisers’s Aura Biosciences AURA Stock Holding History

Two Sigma Advisers’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-14,700
Closed -$131K – 2340
2024
Q3 		$131K Sell
14,700
-20,700
-58% -$177K ﹤0.01% 2137
2024
Q2 		$268K Buy
35,400
+3,900
+12% +$28.6K ﹤0.01% 2120
2024
Q1 		$247K Buy
+31,500
New +$261K ﹤0.01% 2138

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

Two Sigma Advisers's AURA Position: Q4 2024 in Review

Two Sigma Advisers sold out of Aura Biosciences (AURA) in Q4 2024, closing a stake of 14,700 shares — an estimated $131K sold.

Two Sigma Advisers first reported a position in AURA in Q1 2024 and held it in 3 quarters. The position peaked at $268K in Q2 2024. 94 funds tracked by Wall St. Rank hold AURA as of Q4 2024.

  • Two Sigma Advisers reported no remaining Aura Biosciences position as of Q4 2024 after selling out during the quarter.
  • Two Sigma Advisers sold 14,700 Aura Biosciences shares in Q4 2024, an estimated $131K.
  • Two Sigma Advisers first reported a position in Aura Biosciences in Q1 2024 and held it in 3 quarters.
  • Two Sigma Advisers's Aura Biosciences position peaked at $268K in Q2 2024.
  • 94 funds tracked by Wall St. Rank held Aura Biosciences as of Q4 2024.

Based on Two Sigma Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.